Article info

Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy

Authors

  • Lorenzo Iovino Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Laurel A Thur Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Sacha Gnjatic Medicine—Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articlesGoogle scholar articles
  • Aude Chapuis Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USADepartment of Medicine, University of Washington, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Filippo Milano Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USADepartment of Medicine, University of Washington, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Joshua A Hill Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USADepartment of Medicine, University of Washington, Seattle, Washington, USAVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Joshua A Hill; jahill3{at}fredhutch.org
View Full Text

Citation

Iovino L, Thur LA, Gnjatic S, et al
Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy

Publication history

  • Accepted April 15, 2021
  • First published May 13, 2021.
Online issue publication 
May 13, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.